Medtronic launches a European post-marketing study that will look at 12-month data in patients treated with its Arctic Front Advance cryoablation balloon as a treatment for early persistent atrial fibrillation.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BYjpB6
Cap comentari:
Publica un comentari a l'entrada